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Abstract
Background: Intravascular NK-cell lymphoma (IVNKL) is an extremely rare variant of non-Hodgkin lymphoma. To
our knowledge, there are only a few cases reported in the English literature. Here, a case of a 29-year-old male with
IVNKL involving the skin of the trunk and 4 extremities and liver is presented. A comprehensive literature review is
undertaken to summarize the clinical and pathological features of this disorder.
Findings: In our case, large neoplastic lymphoid cells are restricted to the lumen of small vessels and exhibit the
phenotype of a true NK cell. The morphology and immunophenotype, positivity of EBER and NK-cell origin are simi-
lar to other IVNKL cases. In addition, some cases including ours carry a poor prognosis as multiple systems or vital
organs are involved.
Conclusion: In summary, we report a case of an unusual intravascular lymphoma of NK-cell lineage that displays
both clinical and pathological features and compare it with other differential diagnoses. It is important to recognize
this rare entity to make an appropriate diagnosis and achieve a better understanding regarding the treatment and
prognosis.
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Background
Intravascular NK-cell lymphoma (IVNKL) was first re-
ported by Santucci et al. in 2003 [1] and is revealed as
an infiltration of large cells with an NK/T-cell phenotype
(CD3ε+, CD56+, and markers for cytotoxicity +) that is
localized strictly intravascularly. Most of these cases are
Epstein-Barr virus nucleic acid EBER (Epstein-Barr virus-
encoded small RNA) positive and T-cell receptor (TCR)
gene rearrangement negative. Multiple organs may be
involved, resulting in a variety of clinical presentations;
however, the most common locations that are involved
are the skin and the central nervous system (CNS).
IVNKL is an aggressive lymphoma with a variable but
mostly limited response to chemotherapy and an over-
all poor prognosis, especially for those patients with
multi-system involvement.
Intravascular lymphoma (IVL) is a rare entity. This
disorder was first described as angioendotheliomatosis
proliferans systemisata by Pfleger and Tappeiner [2] in
1959. The neoplastic cells were initially believed to be of
endothelial origin; however, subsequent immunohisto-
chemical and molecular studies demonstrated the lymph-
oid nature of the neoplastic cells [3]. Most cases constitute
a variant of an extranodal diffuse large B-cell lymphoma,
and only approximately 10 % of the published cases are of
T-cell or histiocytic origin [4]. To date, relatively few cases
with an NK-cell lineage have been reported in the English
literature (Table 1) [1, 5–12].
Here, we report on a 29-year-old male patient with
IVNKL of the skin with secondary involvement of the
liver and provide a brief literature review, aiming to (i)
emphasize the diagnostic histopathologic features of
this disease, (ii) avoid the trap of misdiagnosis of ma-
lignant or benign diseases, and (iii) achieve a better
understanding of the character and treatment of this
disease.
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Findings
A 29-year-old man presented with erythematous plaques
on the thighs and trunk, low fever, intermittent head-
aches, weight loss and leukopenia. His family history
was significant, as his only sister had acute myeloid
leukemia (M3) several years previously and was cured by
chemotherapy. Physical examination revealed painful,
subtle, ill-defined, irregular, blanching erythematous
patches on the lower and upper extremities and trunk
(Fig. 1a and b) and slight hepatosplenomegaly.
Table 1 Characters of reported cases of IVNKL
Case number/case Age/gender Involved organ(s) Treatment and follow up
1. Santucci et al. [1] 54/M Skin, CNS Chemotherapy, died 17 months after diagnosis
2. Wu et al. [5] 41/M Skin Chemotherapy, alive and event free at 12 months
3. Wu et al. [5] 47/F CNS, bone marrow, kidneys, ovaries, cervix Treatment unclear, died half a month after diagnosis
4. Kuo et al.[6] 71/F Skin Alive 5 months after diagnosis without treatment
5. Song et al. [7] 40/F Skin Chemotherapy, alive and event free at 7 months
6. Nakamichi et al.[8] 23/F Skin Chemotherapy and stem cell transplantation, died of acute GVHD
9 months after diagnosis
7. Cerroni et al. [9] 63/M Skin Chemotherapy, died 6 months after diagnosis
8. Liao et al. [10] 42/F Skin Chemotherapy and radiotherapy, alive with disease 14 months after
diagnosis
9. Gebauer et al.[11] 72/M Skin, bone marrow, CNS Chemotherapy, died 7 months after diagnosis
10. Liu et al. [12] 37/F Skin, CNS Chemotherapy, died 13 months after diagnosis
11.our case 29/M Skin, liver Chemotherapy, died 3 months after diagnosis
Case number/case Immunophenotypes PCR-TCR
CD3 CD4 CD5 CD8 CD20 CD30 CD56 Cytotoxic markers EBER
1. Santucci et al. [1] + - NA - - + + + + ND
2. Wu et al. [5] + - - - - - + + + P
3. Wu et al. [5] + - - - - NA + + - P
4. Kuo et al. [6] + - - - - - + + + P
5. Song et al. [7] + - NA - - NA + + + P
6. Nakamichi et al.[8] + NA NA NA - NA + + + ND
7. Cerroni et al. [9] + - NA - - NA + + + P
8. Liao et al.[10] + - - - - - + + + ND
9. Gebauer et al.[11] + - NA - - - + + + P
10. Liu et al. [12] + - - - - - + + + ND
11.our case + - - - - + + + + P
M, male; F, female
GVHD, graft-versus-host disease
NA, not available
cytotoxic markers, TIA-1 and/or granzyme B and/or perforin
PCR-TCR, polymerase chain reaction analysis of the T-cell receptor g gene
P, polyclonal smear
Fig. 1 a and b Red-violaceous ill-defined and irregular plaques on the lower extremities and trunk
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A biopsy of the erythematous plaques on the right
thigh was performed. The specimen consisted of skin
and subcutaneous tissue and measured 1.2 × 0.9 ×
0.5 cm. The sample was fixed in 10 % buffered forma-
lin and embedded in paraffin. Four-micron sections
were cut and stained with hematoxylin and eosin. The cu-
taneous lesions contained clusters of atypical lymphoid
intravascular cells that were occluding and expanding
the lumina of the dilated vessels throughout the sub-
cutaneous tissue (Fig. 2a and b). Reactive lymphocytes
were observed and were aggregated around the vessels.
The tumor cells were discohensive, large, and pleo-
morphic and had irregular enlarged nuclei with scanty
cytoplasms. Mitotic figures and tumor cell necrosis
were obvious.
Based on immunohistochemical staining, the pheno-
type of the tumor cells was CD3+, CD43+, CD56+,
TIA-1+, CD30+, CD4-, CD5-, CD7-, CD8-, CD20- and
CD79a-. Approximately 90 % of the tumor cell nuclei
were Ki-67 positive. The vascular endothelial cells
were positive for CD31 and CD34, which demonstrated
the intravascular nature of the neoplastic cells (Fig. 3a,
b, c and d). In situ hybridization for EBER revealed
positive signals in virtually all tumor cell nuclei (Fig. 4).
DNA extracted from formalin-fixed paraffin-embedded
samples was analyzed by polymerase chain reaction
(PCR). The molecular study demonstrated a germline
configuration of TCR genes without rearrangements
(Fig. 5).
Further hematologic analysis demonstrated a normal
peripheral blood count (White blood cell count, 5.66x109/L,
Red blood cell count, 4.20×1012/L, Platelet count,
205×109/L) and a deterioration of liver function. A
bone marrow biopsy and cytological examination of
Fig. 2 a and b Intravascular large pleomorphic tumor cells with irregular nuclei and scanty cytoplasm (hematoxylin and eosin stain ×10 and ×100)
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cerebrospinal fluid revealed no evidence of tumor
involvement.
A diagnosis of IVL of the natural killer cell type
was established 6 months after the appearance of
initial skin lesions. The patient received 2 cycles of
combination chemotherapy (cyclophosphamide, Vin-
cristine, Doxorubicin, Dexamethasone; Hyper CVAD).
However, clinical and computed tomography scans
revealed multiple low-density hepatic masses, indicat-
ing liver involvement (Fig. 6a and b). The status of
the patient deteriorated rapidly and he had a fever of
38.5°-39 °C. He died of multi-organ failure 3 months
after diagnosis.
Discussion
Among the 11 reported cases of IVNKL, including the
cases originally published in English and ours, six
(54.5 %) were reported from Asia (2 from China, 2
from Taiwan, 1 from Japan and 1 from Korea), which is
consistent with the distribution characteristics of extra-
nodal NK/T-cell lymphoma, nasal type, which has a
higher incidence in East Asia and Latin America, with
EBV infection occurring in some cases [13]. Of the 11
patients, six were female and five were male. The ages
ranged from 23 to 72 years (median, 47 years). Derma-
tological manifestations were observed in 10 (91 %)
cases. Multisystem involvement occurred in 5 patients,
and 4 of 5 were CNS involvement. After a follow-up
that ranged from half a month to 17 months, 7 of 11
patients died, and only 4 of 11 experienced temporary
remission.
In the 11 cases in which the morphology of the
IVNKL was described, the tumor cells were all confined
within the vessels and had large cell sizes with pale or
eosinophilic cytoplasms and irregular hyperchromatic
nuclei. Mitotic figures and necrosis were routinely ob-
served. In all 11 cases, typical NK cell immunopheno-
types were observed: CD3+; CD56+; TIA-1+; granzyme
Fig. 4 In situ hybridization for EBER showing strong signals in the
tumor cells (×100)
Fig. 3 a, b and c, Immunohistochemical staining for CD3, CD56 and TIA-1, respectively, showing positive staining in the tumor cells (×100).
d Blood vessel endothelial cells surrounding the tumor cells identified by positive staining of CD34 (×40)
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B+; perforin+; CD4-; CD5-; CD8- and CD20-. EBER
detection was performed in 11 cases and was positive
in 10 of the 11 cases, indicating Epstein-Barr virus
(EBV) infection. T-cell gene rearrangement analysis
was performed in 7 of the 11 cases and was negative,
confirming an NK-cell origin.
For diagnosis, large neoplastic lymphoid cells of
IVNKL are restricted to the lumen of small vessels and
exhibit the phenotype of a true NK cell, characterized
by tumor cells with a CD2+, cytoplasmic CD3ε + and
CD56+ immunophenotype and germline configuration
of the TCR gene [14]. Tumor cells also expressed cyto-
toxic granules, including TIA-1, granzyme B and per-
forin, and were often EBV positive. Thus, the similar
morphology and immunophenotype of other cases,
positivity of EBER and NK-cell origin help to confirm
the diagnosis of our case as IVNKL.
As so far, IVNKL is not classified within the World
Health Organization classification subtypes [15]. How-
ever, in view of the unique characteristics of this dis-
ease, the diagnosis should be independent to collect
more data to help with further study of this disease. Be-
cause of the similar morphology and immunopheno-
types, TCR rearrangement results, and EBV infection
status of intravascular NK-cell lymphoma, extranodal
NK/T-cell lymphoma, nasal type (ENKTCL) and ag-
gressive NK-cell leukemia [16, 17], we suggest that
IVNKL should be distinguished from the other two
subtypes. Patients with IVNKL had no nasal symptoms
and obvious abnormalities in the peripheral blood but
had the hallmark of intravascular dissemination of tumor
cells. In ENKTCL and aggressive NK-cell leukemia, tumor
cells were distributed in tissues rather than deposited
in blood vessels. The other differential diagnoses of
IVNKL include IVL of other lineages (in which the
tumor cells have typical immunophenotypes, such as
being positive for B or T-cell markers), metastatic neo-
plasms (for example melanoma or breast cancer, which
are validated by medical history and immunochemical
staining), and numerous inflammatory processes, in-
cluding drug reactions and insect bites, showing atypical
intravascular CD30+ T-cell proliferation mimicking
intravascular lymphoma (which includes variable num-
bers of intravascular CD30-positive cells, but the extent
of the intravascular proliferation is much less florid,
and the cells show a mixture of CD4 and CD8 positivity
without a monoclonal T-cell population by molecular
testing) [18].
Regarding etiological hypotheses, we believe that not
only EBV infection but also genetic inheritance is
somehow involved in the pathogenesis of this rare
lymphoma because of this patient’s remarkable family
history. IVNKL treatments are ineffective and include
chemotherapy, radiotherapy, and even stem cell trans-
plantation, which cannot change the poor prognosis.
Because patients with clinical presentation confined to
skin have a better prognosis, the poor outcome may be
due to multisystem or vital organ involvement.
Consent
Written informed consent was obtained from the pa-
tient’s parents prior to publication of this case report
Fig. 5 Molecular studies revealed a germline configuration for the T-cell receptor that is consistent with the possibility of an NK-cell origin. (L =
Control Size Ladder for samples of unknown quantity and quality, M = DNA ladder marker, TB (A,B,C), TD and TG (A,B) represent 6 tubes of master
mixes for targeting different regions of TCR genes)
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and the accompanying images. A copy of the written
consent is available for review by the Editor-in-Chief of
this journal.
Abbreviations
IVNKL: Intravascular NK-cell lymphoma; EBER: Epstein-Barr virus-encoded
small RNA; TCR: T-cell receptor; CNS: Central nervous system;
IVL: Intravascular lymphoma; DNA: Deoxyribonucleic acid; PCR: Polymerase
chain reaction; EBV: Epstein-Barr virus.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
YLB and ZH were the main authors of the paper, and they equally worked the
case and drafted the manuscript. ZYL and YXM participated in the design of the
study. CWJ and XHS were responsible for the clinical data. LS participated in the
radiological analysis. YFL conducted the immunohistochemical study. QL
conducted the molecular study. THL was the primary pathologist involved in
the case, made the final diagnosis, and was the main editor of the body of the
text. All of the authors read and approved the final manuscript.
Acknowledgements
We thank James B. who provided medical writing services on behalf of
American Journal Experts, LLC.
Fig. 6 Pre-contrast CT images showing multiple low-density hepatic masses with hepatosplenomegaly and bilateral pleural effusion (a). Post-contrast
CT images showing contrast enhancement in the portal venous phase (b)
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